ストックスクリーナーアプリを入手
0.8319
6.24%
-0.0554
アフターアワーズ：
.84
0.0081
+0.97%
前日終値:
$0.8873
開ける：
$0.88
24時間の取引高:
153.51K
Relative Volume:
0.68
時価総額：
$846.89K
収益：
$208.00K
当期純損益:
$-16.89M
株価収益率:
-0.0398
EPS:
-20.8847
ネットキャッシュフロー:
$-16.44M
1週間 パフォーマンス:
-25.05%
1か月 パフォーマンス:
-63.35%
6か月 パフォーマンス:
-92.56%
1年 パフォーマンス:
-99.21%
1日の値動き範囲:
$0.76
$0.88
1週間の範囲:
$0.76
$1.1999
52週間の値動き範囲:
$0.76
$112.50
Glucotrack Inc Stock (GCTK) Company Profile
Compare GCTK vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.8319 | 846.89K | 208.00K | -16.89M | -16.44M | -20.88 |
ABT
Abbott Laboratories
|
104.68 | 181.14B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.45 | 122.09B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
293.23 | 112.48B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.14 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.10 | 50.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glucotrack Inc (GCTK) 最新ニュース
Form 8K GlucoTrack Inc For: 28 September - Investing.com India
GlucoTrack Announces Debt-Reducing Public Equity Offering - theglobeandmail.com
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com Canada
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Yahoo Finance
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Business Wire
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com India
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com UK
Shareholders at Glucotrack (GCTK) sign off on new financing-linked share issuances - Stock Titan
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com India
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Nigeria
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com UK
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Nigeria
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com India
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Canada
Glucotrack Announces $11.5 Million Financing - Finviz
Glucotrack Announces $11.5 Million Financing - marketscreener.com
Glucotrack Announces $11.5 Million Financing - Yahoo Finance
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - kalkinemedia.com
GlucoTrack, Inc. announced that it has received $9.045015 million in funding - marketscreener.com
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
Lōkahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions - Finviz
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - Stock Titan
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - Kalkine Media
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack Inc (GCTK) 財務データ
収益
当期純利益
現金流量
EPS
1.03%
0.17%
大文字化:
|
ボリューム (24 時間):